Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

81.69
Delayed Data
As of 8:00pm ET
 -1.38 / -1.66%
Today’s Change
58.66
Today|||52-Week Range
88.98
+38.01%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Biotech ETF.

Performance

1 month+0.29% 3 years+11.11%
3 months-1.01% 5 years+23.11%
1 year+34.41% Since inception+15.00%
Data through 12/12/2017

Quote Details

Previous close$83.07
Open day’s range81.33 – 83.32
Net asset value (NAV)83.05 (12/11/2017)
Daily volume4,911,950
Average volume (3 months)3,732,577
Data as of 8:00pm ET, 12/12/2017

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+23.11%+16.79%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.841.12
Net assets$4.0B$3.1B
Average market cap$4.6B$27.3B
Average P/E--22.4
Dividend / Share--0.30%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ALNY Alnylam Pharmaceuticals Inc3.53%
EXAS Exact Sciences Corp2.71%
BLUE bluebird bio Inc2.68%
JUNO Juno Therapeutics Inc2.52%
SRPT Sarepta Therapeutics Inc2.50%
NBIX Neurocrine Biosciences Inc2.41%
SGEN Seattle Genetics Inc2.22%
ABBV AbbVie2.19%
UTHR United Therapeutics Corp2.08%
EXEL Exelixis Inc2.02%